Previous Article | Next Article 
Infection and Immunity, December 1998, p. 5607-5612, Vol. 66, No. 12
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Lipopolysaccharide of Bordetella
bronchiseptica Acts as a Protective Shield against
Antimicrobial Peptides
Andreas
Banemann,
Heike
Deppisch, and
Roy
Gross*
Lehrstuhl für Mikrobiologie,
Theodor-Boveri-Institut, Biozentrum der Universität
Würzburg, D-97074 Würzburg, Germany
Received 3 April 1998/Returned for modification 31 July
1998/Accepted 28 September 1998
Resistance profiles of the two Bordetella species
B. bronchiseptica and B. pertussis against
various antimicrobial peptides were determined in liquid survival and
agar diffusion assays. B. bronchiseptica exhibited
significantly higher resistance against all tested peptides than
B. pertussis. The most powerful agents acting on B. bronchiseptica were, in the order of their killing efficiencies,
cecropin P > cecropin B > magainin-II-amide > protamine > melittin. Interestingly, for B. bronchiseptica, the resistance level was significantly affected
by phase variation, as a bvgS deletion derivative showed an
increased sensitivity to these peptides. Tn5-induced
protamine-sensitive B. bronchiseptica mutants, which were
found to be very susceptible to most of the cationic peptides, were
isolated. In two of these mutants, the genetic loci inactivated by
transposon insertion were identified as containing genes highly homologous to the wlbA and wlbL genes of
B. pertussis that are involved in the biosynthesis of
lipopolysaccharide (LPS). In agreement with this finding, the two
peptide-sensitive mutants revealed structural changes in the LPS,
resulting in the loss of the O-specific side chains and the prevalence
of the LPS core structure. This demonstrates that LPS plays a major
role in the resistance of B. bronchiseptica against the
action of antimicrobial peptides and suggests that B. pertussis is much more susceptible to these peptides due to the
lack of the highly charged O-specific sugar side chains.
*
Corresponding author. Mailing address: Lehrstuhl
für Mikrobiologie, Biozentrum, Am Hubland, D-97074
Würzburg, Germany. Phone: (931) 888 4403. Fax: (931) 888 4402. E-mail: roy{at}biozentrum.uni-wuerzburg.de.
Infection and Immunity, December 1998, p. 5607-5612, Vol. 66, No. 12
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Makobongo, M. O., Kovachi, T., Gancz, H., Mor, A., Merrell, D. S.
(2009). In Vitro Antibacterial Activity of Acyl-Lysyl Oligomers against Helicobacter pylori. Antimicrob. Agents Chemother.
53: 4231-4239
[Abstract]
[Full Text]
-
Paterson, G. K., Cone, D. B., Peters, S. E., Maskell, D. J.
(2009). The enzyme phosphoglucomutase (Pgm) is required by Salmonella enterica serovar Typhimurium for O-antigen production, resistance to antimicrobial peptides and in vivo fitness. Microbiology
155: 3403-3410
[Abstract]
[Full Text]
-
Kooi, C., Sokol, P. A.
(2009). Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides. Microbiology
155: 2818-2825
[Abstract]
[Full Text]
-
Westman, E. L., Preston, A., Field, R. A., Lam, J. S.
(2008). Biosynthesis of a Rare Di-N-Acetylated Sugar in the Lipopolysaccharides of both Pseudomonas aeruginosa and Bordetella pertussis Occurs via an Identical Scheme despite Different Gene Clusters. J. Bacteriol.
190: 6060-6069
[Abstract]
[Full Text]
-
Skurnik, M., Biedzka-Sarek, M., Lubeck, P. S., Blom, T., Bengoechea, J. A., Perez-Gutierrez, C., Ahrens, P., Hoorfar, J.
(2007). Characterization and Biological Role of the O-Polysaccharide Gene Cluster of Yersinia enterocolitica Serotype O:9. J. Bacteriol.
189: 7244-7253
[Abstract]
[Full Text]
-
Loutet, S. A., Flannagan, R. S., Kooi, C., Sokol, P. A., Valvano, M. A.
(2006). A Complete Lipopolysaccharide Inner Core Oligosaccharide Is Required for Resistance of Burkholderia cenocepacia to Antimicrobial Peptides and Bacterial Survival In Vivo. J. Bacteriol.
188: 2073-2080
[Abstract]
[Full Text]
-
Yeaman, M. R., Yount, N. Y.
(2003). Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmacol. Rev.
55: 27-55
[Abstract]
[Full Text]
-
Ulvatne, H., Haukland, H. H., Samuelsen, O., Kramer, M., Vorland, L. H.
(2002). Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B. J Antimicrob Chemother
50: 461-467
[Abstract]
[Full Text]
-
Sisti, F., Fernandez, J., Rodriguez, M. E., Lagares, A., Guiso, N., Hozbor, D. F.
(2002). In Vitro and In Vivo Characterization of a Bordetella bronchiseptica Mutant Strain with a Deep Rough Lipopolysaccharide Structure. Infect. Immun.
70: 1791-1798
[Abstract]
[Full Text]
-
Preston, A., Maskell, D.
(2001). Invited review: The molecular genetics and role in infection of lipopolysaccharide biosynthesis in the Bordetellae. Innate Immunity
7: 251-261
-
Schneider, B., Gross, R., Haas, A.
(2000). Phagosome Acidification Has Opposite Effects on Intracellular Survival of Bordetella pertussis and B. bronchiseptica. Infect. Immun.
68: 7039-7048
[Abstract]
[Full Text]
-
West, N. P., Jungnitz, H., Fitter, J. T., McArthur, J. D., Guzman, C. A., Walker, M. J.
(2000). Role of Phosphoglucomutase of Bordetella bronchiseptica in Lipopolysaccharide Biosynthesis and Virulence. Infect. Immun.
68: 4673-4680
[Abstract]
[Full Text]
-
Burtnick, M. N., Woods, D. E.
(1999). Isolation of Polymyxin B-Susceptible Mutants of Burkholderia pseudomallei and Molecular Characterization of Genetic Loci Involved in Polymyxin B Resistance. Antimicrob. Agents Chemother.
43: 2648-2656
[Abstract]
[Full Text]